CGRP ligand drugs for Migraine

3 tracked CGRP ligand drugs in the Migraine race. The class explanation lives on the CGRP ligand page; the full indication pipeline across every mechanism is on the Migraine page.

3 approved / phase 4

Head-to-head evidence: Eptinezumab (Vyepti) vs Fremanezumab (Ajovy) · Eptinezumab (Vyepti) vs Galcanezumab (Emgality) · Fremanezumab (Ajovy) vs Galcanezumab (Emgality)

The roster

← all CGRP ligand drugs